Refined balloon pulmonary angioplasty —A therapeutic option in very elderly patients with chronic thromboembolic pulmonary hypertension

ConclusionThis study demonstrated the safety and efficacy of refined BPA in CTEPH patients aged 75 or over, disqualified from PEA. Refined BPA may emerge as an alternative therapeutic strategy in very elderly CTEPH patients who are suitable for surgery, but this requires further validation in a large prospective study.

Source: Journal of Interventional Cardiology - April 1, 2017 Category: Cardiology Authors: Marek Roik, Dominik Wretowski, Andrzej Łabyk, Katarzyna Irzyk, Barbara Lichodziejewska, Olga Dzikowska‐Diduch, Dorota Piotrowska‐Kownacka, Piotr Pruszczyk Tags: ORIGINAL INVESTIGATION Source Type: research